Price To Earnings Ratio 19.06 | Sector PE 71.26 |
PB Ratio 1.59 | Sector PB 9.10 |
EPS 22.90 | Dividend Yield 1.38 |
Today's Volume 4.195 M | 5 Day Avg. Volume 1.161 M |
PEG Ratio -5.64 | Market Cap. ₹ 2,430.00 Cr. |
IOL Chemicals and Pharmaceuticals Limited is an Indian active ingredient (API) based pharmaceutical company. The company's API portfolio spans several therapeutic categories, including pain management, diabetes, hypertension and anticonvulsants. The company operates through two business divisions: Active Pharma Ingredients (API) and Specialty Chemicals. Its API division is engaged in research, development and supply of key products used by various pharmaceutical companies. Its API portfolio includes ibuprofen, ibuprofen lysinate, ibuprofen sodium, dex-ibuprofen, metformin HCL, clopidogrel hydrogen sulphate (form II), pantoprazole, fenofibrate, gabapentin, lamotrigine, ursodeoxycholic acid, losartan potassium and losartan potassium. Its special chemical division includes ethyl acetate, isobutylbenzene, acetyl chloride and monochloroacetic acid.